Navigation Links
EntreMed Receives Notice of NASDAQ Compliance
Date:10/15/2010

ROCKVILLE, Md., Oct. 15 /PRNewswire/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, today announced that it has received a letter from the NASDAQ Stock Market indicating that it has regained compliance with the minimum $35 million Market Value of Listed Securities ("MVLS") requirement for continued listing on the NASDAQ Capital Market as set forth in NASDAQ Marketplace Rule 5550(b)(2).(Logo: http://photos.prnewswire.com/prnh/20010620/ENMDLOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20010620/ENMDLOGO)

On August 17, the Company received a Staff Determination Letter from NASDAQ stating that it was not in compliance with the rule because its MVLS failed to meet the required $35 million minimum for the last 30 consecutive business days.  At that time, the Company was granted 180 calendar days, or until February 14, 2011, to regain compliance with the rule.  

In order to regain compliance, the Company was required to maintain a $35 million MVLS for a minimum of 10 consecutive business days.  In its October 13, 2010 notification, NASDAQ provided written confirmation that EntreMed has regained compliance with the rule and that this matter is now closed.

About EntreMedEntreMed, Inc. is a clinical-stage pharmaceutical company committed to developing ENMD-2076, a selective angiogenic kinase inhibitor, for the treatment of cancer.  ENMD-2076 is currently in a multi-center Phase 2 study in ovarian cancer and in several Phase 1 studies in solid tumors, multiple myeloma, and leukemia.  Additional information about EntreMed is available on the Company's web site at www.entremed.com and in various filings with the Securities and Exchange Commission.

Forward Looking StatementsThis release contains forward-looking
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
2. EntreMed Raises $20 Million to Support Clinical Development Program
3. EntreMed Reports Phase 1 PK and Preclinical Efficacy Results for ENMD-1198
4. EntreMed Shows Increased Survival With MKC-1 in Preclinical Renal Cell Cancer Model
5. EntreMed Commences Phase 2 Study with MKC-1 in Pancreatic Cancer
6. EntreMed to Present at The New York Society of Security Analysts Industry Conference
7. EntreMed Commences Phase 2 Study With MKC-1 in Ovarian/Endometrial Cancers
8. EntreMed Commences Continuous Dosing Clinical Trial For MKC-1
9. EntreMed Achieves a Key Milestone Through Initiation of ENMD-2076 Clinical Program
10. EntreMed to Highlight ENMD-2076 Kinase Inhibitor at 2008 AACR Annual Meeting
11. EntreMed Presents MKC-1 and ENMD-1198 Preclinical Data at AACR Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... , Dec. 17, 2014  ImmunoCellular Therapeutics, ... US Patent and Trademark Office (USPTO) has issued ... a dendritic cell-based immunotherapeutic vaccine targeting six tumor ... claims of US Patent No. 8,871,211, which issued ... cancer by administering a dendritic cell composition comprising ...
(Date:12/17/2014)... KENNESAW, Ga. and RALEIGH, ... Clinical Trial Marketing Communications, LLC (CTMC), and Integrated ... in patient recruitment and retention for clinical trials ... called Integrated Clinical Trial Marketing Services (i-CTMS). i-CTMS ... and retention services to pharmaceutical, biotechnology and medical ...
(Date:12/15/2014)... , Dec. 12, 2014 Research and Markets ... addition of the "MEMS Gyroscopes Analog Devices ... report to their offering. ... for tactical grade applications made a lot of ... of reliability. They are now accepted in high-reliability ...
Breaking Medicine Technology:ImmunoCellular Therapeutics Announces Issuance of Key Patent For ICT-107 Cancer Vaccine 2Integrated Clinical Trial Services and Clinical Trial Marketing Communications Form Joint Venture 2Integrated Clinical Trial Services and Clinical Trial Marketing Communications Form Joint Venture 3MEMS Gyroscopes Analog Devices ADIS16136 Precision Angular Rate Sensor Reverse Costing Analysis 2
... Glycotex, Inc., a clinical stage biopharmaceutical company, announced ... of the two completed Phase II clinical studies ... the clinicaltrials.gov database.  These clinical studies have evaluated ... in patients undergoing carbon dioxide laser skin resurfacing. ...
... Street Healthcare Partners , a strategic private equity firm ... has acquired MarketLab, Inc.  Water Street,s investment ... healthcare distribution sector.  The acquisition expands Water Street,s current ... sciences, medical devices and services to 13. ...
Cached Medicine Technology:Glycotex, Inc. Releases Final Phase II Clinical Trials Results in the Clinicaltrials.gov Database and Announces the Results of the Mechanism of Action Study for its Product Candidate GLYC-101 2Glycotex, Inc. Releases Final Phase II Clinical Trials Results in the Clinicaltrials.gov Database and Announces the Results of the Mechanism of Action Study for its Product Candidate GLYC-101 3Glycotex, Inc. Releases Final Phase II Clinical Trials Results in the Clinicaltrials.gov Database and Announces the Results of the Mechanism of Action Study for its Product Candidate GLYC-101 4Water Street Healthcare Partners Acquires MarketLab, Inc. 2Water Street Healthcare Partners Acquires MarketLab, Inc. 3
(Date:12/20/2014)... Parker & Sons, Inc. a focused ... experience in contractor services announces reaching a milestone by ... homeowners of Arizona. Parker and Sons is comprised of ... that make customer service the number one priority. The ... started with one service vehicle and has since grown ...
(Date:12/19/2014)... 2014 Sweetdressy.com , a leading ... its newest selection of cheap prom dresses for ladies ... in the world and clients can buy these dresses ... prom dresses feature cool cuts and delicate craftsmanship, and ... the middle-end market. Discount shipping costs are available for ...
(Date:12/19/2014)... (PRWEB) December 19, 2014 Silver Dollar ... official world record -- for the first time ever, Silver ... record book, Guinness World Records 2015, listing the park’s wood ... Roller Coaster. In additional awards announced this week, Silver Dollar ... Christmas Lights in the US,” USA Today’s 10Best awards for ...
(Date:12/19/2014)... December 20, 2014 An evening dress is ... a lady’s closet. Discount-Dress.com, a distinguished dresses retailer, has unveiled ... beautiful dresses in this great shopping platform. Customers can ... the staff's hard work, Discount-Dress.com has been accepted and praised ... faster and easier shopping stage for clients. In order to ...
(Date:12/19/2014)... -- The intestinal bacteria that cause inflammatory bowel disease, ... inherited, researchers report. The findings, published recently in ... efforts to prevent the disease and treat the 1.6 ... added. "The intestinal bacteria, or ,gut microbiome, you ... big impact on your health for the rest of ...
Breaking Medicine News(10 mins):Health News:Parker & Sons Announces Reaching A Milestone By Providing 40 Years Of Dedicated Contractor Services For Homeowners Of Arizona 2Health News:Parker & Sons Announces Reaching A Milestone By Providing 40 Years Of Dedicated Contractor Services For Homeowners Of Arizona 3Health News:Cheap Prom Dresses Online Now at Sweetdressy.com 2Health News:Silver Dollar City Nets New Titles: Guinness Book of World Records, Plus CNN Travel, USA Today & Fodor’s Top Places for Christmas Lights 2Health News:Attractive Evening Dresses Announced by Discount-Dress.com 2Health News:Crohn's, Colitis May Have Genetic Underpinnings, Study Finds 2
... in the human diet mean people today are more at ... said.Researchers at the University of Newcastle believe that changes to ... off its anti-cancer agents. ,The researchers are working ... in fighting stomach cancer. They are carrying out two trials ...
... an amino-acid taste receptor.Dr Charles S. Zuker, from ... of California, San Diego, reports his team's findings ... tastes — bitter, salty, sour, sweet, and umami. ... (MSG).Receptors that responded to umami have been discovered ...
... are associated with permutation in brain structure that appear ... conducted by researchers at the University of Iowa.// ... and 54 male control subjects, the researchers used magnetic ... They found that the volume of the anterior portion ...
... shun most of the dangers of developing lung cancer. There are ... are former smokers compared with those who continue to smoke.// Over ... lung cancer in the world. ,One of the authors ... study in 1950 established the smoking and lung cancer link. A ...
... pollutant emitted by power plants and vehicles raises the ... of dying from lung cancer or heart disease//, and ... authors contend that simply living in a major urban ... its way into your lungs when you breathe, increasing ...
... exercise cut the risk of diabetes by over half. ... be at increased risk of developing diabetes.// Given that ... very useful if there was some way of helping ... for the Diabetes Prevention Programme in the US have ...
Cached Medicine News:Health News:Comprehension of taste receptor, 2
... and comfortable eye protection Properly manufactured ... of scatter radiation. Our high quality frames ... comfort with minimized weight. Our lenses are ... that meet all industry standards. Most Pulse ...
... with the safety and comfort of the practitioner ... called SF-6) leaded glass, the industry standard for ... set for optical clarity, visible light transmission, power ... protecting your eyes, it also helps you look ...
Uvex Patriot Frame...
... Both lenses and frames are designed with ... mind. Our lenses are Schott RS-520 (also called ... shielding glass. These lenses meet standards, as set ... prism correction. ,While our eyewear is protecting ...
Medicine Products: